5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

被引：871

作者：

Cardoso, F. ^{[1
]}

Paluch-Shimon, S. ^{[2
]}

Senkus, E. ^{[3
]}

Curigliano, G. ^{[4
]}

Aapro, M. S. ^{[5
]}

Andre, F. ^{[6
]}

Barrios, C. H. ^{[7
]}

Bergh, J. ^{[8
,9
]}

Bhattacharyya, G. S. ^{[10
]}

Biganzoli, L. ^{[11
]}

Boyle, F. ^{[12
]}

Cardoso, M-J ^{[1
,13
]}

Carey, L. A. ^{[14
]}

Cortes, J. ^{[15
,16
,17
]}

El Saghir, N. S. ^{[18
]}

Elzayat, M. ^{[19
]}

Eniu, A. ^{[20
]}

Fallowfield, L. ^{[21
]}

Francis, P. A. ^{[22
]}

Gelmon, K. ^{[23
]}

Gligorov, J. ^{[24
]}

Haidinger, R. ^{[25
]}

Harbeck, N. ^{[26
]}

Hu, X. ^{[27
]}

Kaufman, B. ^{[28
]}

Kaur, R. ^{[29
]}

Kiely, B. E. ^{[30
]}

Kim, S-B ^{[31
]}

Lin, N. U. ^{[32
]}

Mertz, S. A. ^{[33
]}

Neciosup, S. ^{[34
]}

Offersen, B., V ^{[35
]}

Ohno, S. ^{[36
]}

Pagani, O. ^{[37
]}

Prat, A. ^{[38
,39
,40
]}

Penault-Llorca, F. ^{[41
,42
]}

Rugo, H. S. ^{[43
]}

Sledge, G. W. ^{[44
]}

Thomssen, C. ^{[45
]}

Vorobiof, D. A. ^{[46
]}

Wiseman, T. ^{[47
]}

Xu, B. ^{[48
]}

Norton, L. ^{[49
]}

Costa, A. ^{[50
,51
]}

Winer, E. P. ^{[32
]}

机构：

[1] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal

[2] Hadassah Univ Hosp, Sharett Div Oncol, Jerusalem, Israel

[3] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[4] Univ Milan, European Inst Oncol, Dept Oncol & Hematooncol, Div Early Drug Dev,IRCCS, Milan, Italy

[5] Clin Genolier, Breast Ctr, Genolier, Switzerland

[6] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[7] Grp Oncoclin, Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil

[8] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[9] Univ Hosp, Stockholm, Sweden

[10] Salt Lake City Med Ctr, Dept Med Oncol, Kolkata, India

[11] Nuovo Osped Prato Ist Toscano Tumori, Dept Med Oncol, Prato, Italy

[12] Royal North Shore Hosp, Pam McLean Ctr, St Leonards, NSW, Australia

[13] Nova Med Sch, Lisbon, Portugal

[14] UNC Lineberger Comprehens Canc Ctr, Dept Hematol & Oncol, Chapel Hill, NC USA

[15] Quiron Grp, IOB Inst Oncol, Madrid, Spain

[16] Quiron Grp, IOB Inst Oncol, Barcelona, Spain

[17] Vall dHebron Inst Oncol, Dept Oncol, Barcelona, Spain

[18] Amer Univ Beirut, Dept Internal Med, Div Hematol Oncol, Med Ctr, Beirut, Lebanon

[19] European Breast Canc Coalit, Europa Donna, Milan, Italy

[20] Riviera Chablais Hosp, Interdisciplinary Oncol Serv SIC, Rennaz, Switzerland

[21] Univ Sussex, Brighton & Sussex Med Sch, SHORE C, Brighton, E Sussex, England

[22] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[23] BC Canc Agcy, Med Oncol Dept, Vancouver, BC, Canada

[24] Sorbonne Univ, AP HP, Breast Canc Expert Ctr, Univ Canc Inst, Paris, France

[25] Brustkrebs Deutschland eV, Munich, Germany

[26] Univ Munich LMU, Breast Ctr, Dept Obstet & Gynaecol, Munich, Germany

[27] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China

[28] Sheba Med Ctr, Dept Oncol, Ramat Gan, Israel

[29] Breast Canc Welf Assoc Malaysia, Petaling Jaya, Malaysia

[30] Sydney Med Sch, NHMRC Clin Trials Ctr, Sydney, NSW, Australia

[31] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea

[32] Dana Farber Canc Inst, Susan Smith Ctr Womens Canc, Breast Oncol Ctr, Boston, MA 02115 USA

[33] Metastat Breast Canc Network, Inverness, IL USA

[34] Natl Inst Neoplast Dis, Dept Med Oncol, Lima, Peru

[35] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark

[36] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan

[37] Geneva Univ Hosp, Med Sch, Geneva, Switzerland

[38] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[39] IDIBAPS, Translat Genom & Targeted Therapies Solid Tumors, Barcelona, Spain

[40] Univ Barcelona, Dept Med, Barcelona, Spain

[41] Ctr Jean Perrin, Dept Biopathol, Clermont Ferrand, France

[42] Univ Clermont Auvergne, INSERM U1240, Clermont Ferrand, France

[43] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Oncol Clin Trials Educ, San Francisco, CA USA

[44] Stanford Sch Med, Div Oncol, Stanford, CA 94305 USA

[45] Martin Luther Univ Halle Wittenburg, Dept Gynaecol, Halle, Germany

[46] BelongLife, Oncol Res Unit, Tel Aviv, Israel

[47] Royal Marsden Hosp NHS Fdn Trust, Dept Appl Hlth Res Canc Care, London, England

[48] Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing, Peoples R China

[49] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, 1275 York Ave, New York, NY 10021 USA

[50] European Sch Oncol, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 12期

关键词：

ABC; advanced; breast cancer; ESO-ESMO; guidelines; metastatic; QUALITY-OF-LIFE; HORMONE REPLACEMENT THERAPY; MONARCH; ABEMACICLIB; PLUS FULVESTRANT; PHASE-III; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; VASOMOTOR SYMPTOMS; CONTROLLED-TRIAL; VAGINAL DRYNESS;

D O I：

10.1016/j.annonc.2020.09.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1623 / 1649

页数：27

共 141 条

[1] ABC Global Alliance, 2018, ABC GLOB CHART 2018
[2] Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
Adam, J.
Le Stang, N.
Rouquette, I.
Cazes, A.
Badoual, C.
Pinot-Roussel, H.
Tixier, L.
Danel, C.
Damiola, F.
Damotte, D.
Penault-Llorca, F.
Lantuejoul, S.
[J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 953 - 958
[3] Liquid biopsy in breast cancer: A comprehensive review
Alimirzaie, Sahar
Bagherzadeh, Maryam
Akbari, Mohammad R.
[J]. CLINICAL GENETICS, 2019, 95 (06) : 643 - 660
[4] Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Allison, Kimberly H.
Hammond, M. Elizabeth H.
Dowsett, Mitchell
McKernin, Shannon E.
Carey, Lisa A.
Fitzgibbons, Patrick L.
Hayes, Daniel F.
Lakhani, Sunil R.
Chavez-MacGregor, Mariana
Perlmutter, Jane
Perou, Charles M.
Regan, Meredith M.
Rimm, David L.
Symmans, W. Fraser
Torlakovic, Emina E.
Varella, Leticia
Viale, Giuseppe
Weisberg, Tracey F.
McShane, Lisa M.
Wolff, Antonio C.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) : 1346 - +
[5] Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Alves, Patricia
Amaral, Cristina
Teixeira, Natercia
Correia-da-Silva, Georgina
[J]. PHARMACOLOGICAL RESEARCH, 2020, 157
[6] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Andre, Fabrice
Ciruelos, Eva
Rubovszky, Gabor
Campone, Mario
Loibl, Sibylle
Rugo, Hope S.
Iwata, Hiroji
Conte, Pierfranco
Mayer, Ingrid A.
Kaufman, Bella
Yamashita, Toshinari
Lu, Yen-Shen
Inoue, Kenichi
Takahashi, Masato
Papai, Zsuzsanna
Longin, Anne-Sophie
Mills, David
Wilke, Celine
Hirawat, Samit
Juric, Dejan
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) : 1929 - 1940
[7] Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[8] [Anonymous], 2019, MED LETT DRUGS THER, V61, P179
[9] [Anonymous], 2016, OBSTET GYNECOL, V127, pE93
[10] [Anonymous], 2017, BREAST S1

← 1 2 3 4 5 6 7 8 9 10 →